Showing results (921-930 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|March 5, 2024
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programmeJoão Pedro Ferreira, Milton Packer, Naveed Sattar, et al.
European Journal of Heart Failure|February 26, 2024
Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertensionMichele D'Alto, Marco Di Maio, Paola Argiento, et al.
European Journal of Heart Failure|February 26, 2024
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathyMartina Setti, Marco Merlo, Marta Gigli, et al.
European Journal of Heart Failure|February 21, 2024
Use of natriuretic peptides and echocardiography for diagnosing heart failureKhawaja M Talha, James L Januzzi, Tong Meng, et al.
European Journal of Heart Failure|November 22, 2023
Rationale and design of the ESC Heart Failure III Registry - Implementation and discoveryLars H Lund, Maria Generosa Crespo-Leiro, Cecile Laroche, et al.
European Journal of Heart Failure|November 21, 2023
Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trialSheldon E Litwin, Jan Komtebedde, Tim Seidler, et al.
European Journal of Heart Failure|November 15, 2023
Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR programJoão Pedro Ferreira, Milton Packer, Javed Butler, et al.
European Journal of Heart Failure|November 7, 2023
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registryDaniela Tomasoni, Matteo Pagnesi, Giada Colombo, et al.
European Journal of Heart Failure|October 31, 2023
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathiesMarija Polovina, Carsten Tschöpe, Giuseppe Rosano, et al.
European Journal of Heart Failure|November 13, 2023
Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?Yousuf Razvi, Adam Ioannou, Rishi K Patel, et al.
Pageof 398